explore -WSS

explore

author：entertainment 2025-09-30 19:03:23 - browse：553

A psilocybin mushroom lays inside a clear capsule — Adobe

A single dose of psilocybin may have enduring benefits for people with major depressive disorder, according to a randomized clinical trial published Thursday in the Journal of the American Medical Association.

Several prior studies have suggested that psilocybin, the psychedelic compound produced by certain types of mushrooms, could be a promising way to treat major depression in people for whom antidepressants or counseling aren’t effective. But those studies mostly focused on short-term results, while the new JAMA study looked at psilocybin’s efficacy up to six weeks after the administration of a single dose of psilocybin.

“It’s exciting to see another study that’s coming out that is adding to the evidence base suggesting potential efficacy of psilocybin for depression, amongst other conditions,” said Greg Fonzo, an assistant professor and co-director for the Center for Psychedelic Research and Therapy at the University of Texas at Austin’s Dell Medical School, who was not involved in the study.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Ebola vaccine can save some who are already sick, per new study

leisure time

WSS

Congress might make insulin pumps more accessible to the blind

How doctors’ personal politics affect patients

CDC Director Mandy Cohen on transparency, trust, and health

Too many hospitalized Covid

Websites selling Wegovy, Zepbound ingredients targeted by FDA

Roche’s Alnylam deal shows drug firms interested in heart drugs

explore

explore

explore

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Bronny James, LeBron's son, suffers cardiac arrest during basketball practice at USC

Medicare details structure of new drug price negotiation program

Dems pitch expanding Medicare power to negotiate drug prices

Medical leaders decry Supreme Court decision on affirmative action

What to watch for from Zogenix and Amicus clinical trials

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

ACIP vaccine advisory panel sees its vacancies filled

George Santos makes 1st court appearance after pleading not guilty to 13 counts

STAT Report: Patient voices and perspectives

hotspot

New Alzheimer's drugs heat up race for early detection blood tests

Former reverend arrested for allegedly killing 8

A new crop of companies is reshaping the health data economy

Former reverend arrested for allegedly killing 8

'Investigate these claims': UFO transparency at center of House hearing

Having children helps parents live longer, especially after age 80

hotspot

leisure time

explore

explore